(CNX) CNX Resources - Ratings and Ratios
Natural Gas, Midstream Services, Water
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 33.0% |
| Value at Risk 5%th | 53.5% |
| Relative Tail Risk | -1.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.11 |
| Alpha | -7.82 |
| CAGR/Max DD | 0.91 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.558 |
| Beta | 0.406 |
| Beta Downside | 0.597 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.37% |
| Mean DD | 10.82% |
| Median DD | 8.13% |
Description: CNX CNX Resources November 06, 2025
CNX Resources Corp (NYSE:CNX) is an independent natural-gas and midstream firm focused on the Appalachian Basin. It acquires, explores, develops and produces shale and coal-bed methane (CBM) assets across Pennsylvania, West Virginia, Ohio and several adjacent states, and sells pipeline-quality gas to wholesalers. The company also builds and operates roughly 2,700 mi of gathering pipelines and associated processing facilities, and provides water-management services to its own and third-party operations.
Key operational metrics (2023) include an average production of about 1.2 billion cubic feet per day (Bcf/d) and adjusted EBITDA of roughly $350 million, reflecting a cash-flow conversion rate near 85 %. CNX’s exposure to the Marcellus and Utica shales ties its performance to regional natural-gas price spreads, which have been supported by rising demand for LNG export capacity and constrained pipeline bottlenecks in the Northeast. A material driver of future earnings is the company’s ability to monetize CBM reserves in Virginia and New Mexico, where lower-cost gas can offset volatility in the broader market.
For a deeper quantitative view, the ValueRay platform offers granular financial and operational metrics for CNX that can help you assess the trade-off between its growth prospects and balance-sheet risk.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (292.3m TTM) > 0 and > 6% of Revenue (6% = 123.7m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 4.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -34.16% (prev -40.88%; Δ 6.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.00b > Net Income 292.3m (YES >=105%, WARN >=100%) |
| Net Debt (2.80b) to EBITDA (1.06b) ratio: 2.65 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (171.7m) change vs 12m ago -4.11% (target <= -2.0% for YES) |
| Gross Margin 65.06% (prev 59.97%; Δ 5.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 23.65% (prev 16.04%; Δ 7.61pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.91 (EBITDA TTM 1.06b / Interest Expense TTM 171.2m) >= 6 (WARN >= 3) |
Altman Z'' 0.96
| (A) -0.08 = (Total Current Assets 360.9m - Total Current Liabilities 1.07b) / Total Assets 8.90b |
| (B) 0.21 = Retained Earnings (Balance) 1.87b / Total Assets 8.90b |
| (C) 0.06 = EBIT TTM 497.7m / Avg Total Assets 8.72b |
| (D) 0.39 = Book Value of Equity 1.86b / Total Liabilities 4.79b |
| Total Rating: 0.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 60.16
| 1. Piotroski 6.0pt |
| 2. FCF Yield 6.98% |
| 3. FCF Margin 27.86% |
| 4. Debt/Equity 0.68 |
| 5. Debt/Ebitda 2.65 |
| 6. ROIC - WACC (= 0.44)% |
| 7. RoE 7.27% |
| 8. Rev. Trend -53.36% |
| 9. EPS Trend 9.91% |
What is the price of CNX shares?
Over the past week, the price has changed by -0.22%, over one month by -1.15%, over three months by +14.98% and over the past year by +0.96%.
Is CNX a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 3
- Strong Sell: 3
What are the forecasts/targets for the CNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.5 | -6.7% |
| Analysts Target Price | 34.5 | -6.7% |
| ValueRay Target Price | 45.3 | 22.3% |
CNX Fundamental Data Overview December 21, 2025
P/E Trailing = 22.8364
P/E Forward = 16.0772
P/S = 2.8172
P/B = 1.3001
P/EG = 0.96
Beta = 0.644
Revenue TTM = 2.06b USD
EBIT TTM = 497.7m USD
EBITDA TTM = 1.06b USD
Long Term Debt = 2.25b USD (from longTermDebt, last quarter)
Short Term Debt = 405.5m USD (from shortTermDebt, last quarter)
Debt = 2.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.80b USD (from netDebt column, last quarter)
Enterprise Value = 8.24b USD (5.44b + Debt 2.80b - CCE 4.74m)
Interest Coverage Ratio = 2.91 (Ebit TTM 497.7m / Interest Expense TTM 171.2m)
FCF Yield = 6.98% (FCF TTM 574.6m / Enterprise Value 8.24b)
FCF Margin = 27.86% (FCF TTM 574.6m / Revenue TTM 2.06b)
Net Margin = 14.17% (Net Income TTM 292.3m / Revenue TTM 2.06b)
Gross Margin = 65.06% ((Revenue TTM 2.06b - Cost of Revenue TTM 720.5m) / Revenue TTM)
Gross Margin QoQ = 46.81% (prev 73.69%)
Tobins Q-Ratio = 0.92 (Enterprise Value 8.24b / Total Assets 8.90b)
Interest Expense / Debt = 1.53% (Interest Expense 43.0m / Debt 2.80b)
Taxrate = 23.93% (63.6m / 265.7m)
NOPAT = 378.6m (EBIT 497.7m * (1 - 23.93%))
Current Ratio = 0.34 (Total Current Assets 360.9m / Total Current Liabilities 1.07b)
Debt / Equity = 0.68 (Debt 2.80b / totalStockholderEquity, last quarter 4.12b)
Debt / EBITDA = 2.65 (Net Debt 2.80b / EBITDA 1.06b)
Debt / FCF = 4.87 (Net Debt 2.80b / FCF TTM 574.6m)
Total Stockholder Equity = 4.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.28% (Net Income 292.3m / Total Assets 8.90b)
RoE = 7.27% (Net Income TTM 292.3m / Total Stockholder Equity 4.02b)
RoCE = 7.94% (EBIT 497.7m / Capital Employed (Equity 4.02b + L.T.Debt 2.25b))
RoIC = 5.79% (NOPAT 378.6m / Invested Capital 6.53b)
WACC = 5.35% (E(5.44b)/V(8.24b) * Re(7.51%) + D(2.80b)/V(8.24b) * Rd(1.53%) * (1-Tc(0.24)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -4.09%
[DCF Debug] Terminal Value 77.33% ; FCFE base≈411.0m ; Y1≈385.8m ; Y5≈360.6m
Fair Price DCF = 44.74 (DCF Value 6.46b / Shares Outstanding 144.3m; 5y FCF grow -7.86% → 3.0% )
EPS Correlation: 9.91 | EPS CAGR: 12.99% | SUE: 1.17 | # QB: 3
Revenue Correlation: -53.36 | Revenue CAGR: -11.13% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.74 | Chg30d=+0.016 | Revisions Net=-1 | Analysts=6
EPS next Year (2026-12-31): EPS=2.69 | Chg30d=+0.076 | Revisions Net=+1 | Growth EPS=+20.6% | Growth Revenue=-2.7%
Additional Sources for CNX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle